Activated RARα counteracts the effects of TACC1v25 on the differentiation and invasion of head and neck squamous cell carcinoma

Xiao-Li Ge, Chen-Yang Zhang, Pan Xu, Ran Zhao, Hai-Yan Wang, Wei-Wen Jiang · 2025

Read Activated RARα counteracts the effects of TACC1v25 on the differentiation and invasion of head and neck squamous cell carcinoma by Xiao-Li Ge, Chen-Yang Zhang, Pan Xu, Ran Zhao, Hai-Yan Wang, Wei-Wen Jiang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12776186.txt.

Description

Xiao-Li Ge and co-authors published this 2025 study on a shortened protein variant in head and neck cancer. The variant, TACC1v25, comes from a protein that steers cell growth and maturation. Its full-length parent is known to bind a vitamin A receptor called RARα, but the ties of the short form to that receptor in this cancer were unexplored.

Tests showed the variant does bind the receptor, sharing spots in the cell nucleus and body. A vitamin A drug shifted the balance of the pair between those spots. Extra variant protein pushed cancer cells to mature, yet the drug undid that push in one cell line. Gene readouts and a mouse model backed the lab findings.

Catalog record

CREATORXiao-Li Ge, Chen-Yang Zhang, Pan Xu, Ran Zhao, Hai-Yan Wang, Wei-Wen Jiang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12776186

Browse the full library · About the Tower of Babel